Tonix Pharmaceuticals Holding Corp (TNXP)
Cost of Revenue
$703.00K
Quarterly · Period ending: · USD
TNXP Cost of Revenue
Latest reported$703.00Kperiod ending
Latest reported$703.00Kperiod ending
TNXP Quarterly Cost of Revenue ($0.00 → $703.00K)
Quarterly cost of revenue
High-resolution chart · PNG
TNXP cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 703,000 | |
| 2,133,000 | |
| 1,546,000 | |
| 1,367,000 | |
| 3,272,000 | |
| 943,000 | |
| 1,183,000 | |
| 1,555,000 | |
| 3,367,000 | |
| 1,660,000 | |
| 3,858,000 | |
| 2,374,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 7,891,000 | |
| 5,906,000 | |
| 6,297,000 | |
| 0 | |
| 5,541,000 | |
| 6,143,000 | |
| 6,988,000 | |
| 21,291,000 | |
| 5,835,000 | |
| 4,822,000 | |
| 5,091,000 | |
| 38,969,000 | |
| 7,609,000 | |
| 9,836,000 | |
| 14,014,000 | |
| 48,162,000 | |
| 13,280,000 | |
| 11,784,000 | |
| 9,696,000 | |
| 27,656,000 | |
| 7,434,000 | |
| 6,049,000 | |
| 5,169,000 | |
| 10,888,000 | |
| 3,091,680 | |
| 2,085,689 | |
| 2,001,225 | |
| 6,661,410 | |
| 1,734,342 | |
| 1,850,939 | |
| 1,160,365 | |
| 3,378,528 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 8,500 | |
| 8,500 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |